Recently, the application of a drug developed to assist with ion channel trafficking to the cell membrane in cystic fibrosis has shown promise for rescuing the phenotype of LQTS in patients with trafficking defects in hERG [30]. Here, KCNH2 is linked to familial long QT syndrome.